WE ARE ON A MISSION
TO CREATE A CANCER-FREE WORLD
“In 2018, there were an estimated 17 million new cases of cancer worldwide. This is predicted to rise to 27.5 million new cases per year by 2040.” – Cancer Research UK, 2019.
Treatments and diagnostics are continuously improving but research projects and startups are facing numerous challenges and not getting sufficient funding they would need for their take-off.
That’s due to among others the lack of social capital, communication constraints and geographical distance. Our aim is to plug the devoted researchers and entrepreneurs into the right ecosystem and help them grow.
Our team is devoted to provide a platform for innovation and facilitate the work of researchers and entrepreneurs, and eventually find a solution for one of the biggest issues of our society.
MOST COMMON OBSTACLES
Innovators in the cancer diagnostics and treatment sphere are facing several challenges. Many promising projects fail due to:
• Limited visibility
• Lack of resources
• Weak connectivity in the ecosystem
• Misplaced skills and talent
• Isolated projects
• Market noise
We help our teams to overcome these obstacles by providing the support that they need without taking equity stake.
HOW WE DO IT
cLAB connects the dots – and players – through corporate programmes, events, workshops and matchmaking platforms.
Corporate Innovation Programmes:
We find and integrate innovative solutions for corporations to maintain their competitive edge. We offer different levels of cooperation from scouting to full corporate integration.
Our platform increases the efficiency of the investor, client, mentor and talent matchmaking. We carefully select every participants to make sure that our network is qualified.
Events & Workshops:
Through our sector-specific gatherings, we create opportunities for professional development, networking and ideation.
cLAB is a catalyst tool for international development. We mentor our teams and follow their progress through face-to-face sessions, workshops, hackathons and webinars.
Find out more from our short presentation